Artecel

Artecel was a biotechnology company focused on the development of therapeutic applications using adipose-derived adult stem cells (ADSCs). Founded as a spin-out from Duke University and UCLA, the company was a pioneer in identifying the regenerative potential of cells found in human fat tissue. Its research focused on utilizing these autologous stem cells for soft tissue repair, cardiovascular regeneration, and metabolic disorders. In 2003, Artecel was acquired by Cytori Therapeutics (formerly Macropore Biosurgery), which integrated Artecel's extensive patent portfolio into its own regenerative medicine platform. This acquisition was instrumental in the development of automated systems for real-time cell processing in clinical settings. The company's legacy remains central to the field of adipose-derived regenerative medicine.